Multivessel disease in primary percutaneous coronary intervention

G. Belli, P. Presbitero

Research output: Contribution to journalArticlepeer-review


Primary percutaneous coronary intervention (PCI) is currently the preferred revascularization strategy in acute trasmural myocardial infarction (AMI). In this setting, about one half of patients will be diagnosed with concomitant multivessel (MV) coronary artery disease, associated with a multitude of negative prognostic factors but also still an independent predictor of adverse cardiac events and increased long-term mortality. Since additional "angiographic" lesions found at primary PCI are not directly responsile for the acute presentation, their treatment represents a difficult decision-making problem in cardiology. The article summarizes available clinical data on treatment in this setting and also review our current understanding of short-term progression of atherosclerosis after AMI.

Original languageEnglish
Pages (from-to)195-201
Number of pages7
JournalMinerva Cardioangiologica
Issue number3
Publication statusPublished - Jun 2012


  • Atherosclerosis
  • Coronary artery disease
  • Myocardial infarction
  • Myocardial revascularization
  • Prognosis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Multivessel disease in primary percutaneous coronary intervention'. Together they form a unique fingerprint.

Cite this